Fig. 4 | Scientific Reports

Fig. 4

From: The downregulation of SASH1 expression promotes breast cancer occurrence and invasion accompanied by the activation of PI3K-Akt-mTOR signaling pathway

Fig. 4

The rate of SASH1 mutations in breast cancer. (A), the mutation rate of SASH1 is relatively high in breast cancer. (B), the differential expression of SASH1 in breast cancer was observed in both breast cancer datasets. Patients were divided into a breast cancer group and a healthy control group. A linear model combined with the Empirical Bayes approach in the limma package was used to perform differential analysis between the two groups. (C), SASH1 has a high predictive value for the risk of breast cancer occurrence. SASH1, SAM—and SH3 domain containing 1.

Back to article page